Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-027526
Filing Date
2013-05-14
Accepted
2013-05-14 13:22:07
Documents
1
Period of Report
2013-05-10

Document Format Files

Seq Description Document Type Size
1 rrd379384.html 4  
1 rrd379384.xml 4 3857
  Complete submission text file 0001181431-13-027526.txt   5459
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Issuer) CIK: 0001356857 (see all company filings)

EIN.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KLEINER PERKINS CAUFIELD & BYERS 2750 SAND HILL ROAD MENLO PARK CA 94025
Business Address C/O KLEINER PERKINS CAUFIELD & BYERS 2750 SAND HILL ROAD MENLO PARK CA 94025 650-233-2750
KPCB PBD Founders Fund, LLC (Reporting) CIK: 0001497522 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34828 | Film No.: 13840493